Enhanced Equity Fund Invests in Specialty Therapeutic Care

Pittsburgh, PA - January, 2011. Enhanced Equity Fund (“EEF”), a private equity firm investing in leading, lower-middle market healthcare services companies, recently announced its investment in Specialty Therapeutic Care (“STC”), a rapidly growing national specialty pharmacy, providing healthcare management, pharmacy and delivery services to patients primarily suffering from chronic bleeding disorders, such as hemophilia. The transaction was led by Christopher J. Garcia and Kenton Rosenberry, both Partners at EEF.

The Braff Group (TBG) served as exclusive merger and acquisition advisor for Specialty Therapeutic Care.

“STC delivers differentiated, high-touch service to its patients and represents a very strong platform within the specialty pharmacy industry.” said Mr. Rosenberry. “We look forward to partnering with the dedicated and focused management team of STC to further the company’s rapid growth through a continued commitment to excellent patient care.”

“We are committed to expanding upon STC’s exceptional growth, which has averaged almost 100% annually since 2006, and will provide the necessary capital to take advantage of increasing organic growth opportunities as well as fund strategic acquisitions, with the ultimate goal of establishing STC as a leader within the specialty pharmaceutical industry serving a number of different disease states and patient communities,” added Mr. Garcia.

“We chose to partner with EEF given their collective experience and relationships within the industry and feel confident that they will provide us with the guidance and resources necessary to realize the many opportunities for growth available in the specialty pharmaceutical sector,” said Matt Angell, Founder and President of STC.

“The transaction was particularly notable in that, according to proprietary Braff Group research, it represents the seventh platform acquisition of a specialty pharmacy provider by a private equity sponsor in 2010,” commented Reg Blackburn, TBG Managing Director for Pharmacy Services who headed up the deal team representing STC. “The seven deals are a record in the sector, far surpassing the previous high of three private equity led platform deals completed in 2003.  Not only does this demonstrate the confidence the finance community has in the continued growth and opportunity in the specialty pharmacy arena, it also portends well for a potential surge in additional ‘follow-on’ transactions as these firms continue to build-out their offerings.”

About Specialty Therapeutic Care

STC, founded in 2006 and based in Houston, TX, is a national specialty pharmacy, currently licensed in 19 States, and a leading distributor of various blood products and pharmaceuticals to treat a wide array of bleeding disorders. The Company is dedicated to meeting the specialized needs of individuals with chronic or life-threatening illnesses and is continually devoted to providing efficient and compassionate treatment that extends beyond traditional service parameters by actively working with patients, physicians, health plans, patient advocacy organizations and pharmaceutical companies. STC’s commitment to superior patient care and service has driven outstanding revenue growth of almost 100% annually since 2006.

About The Braff Group

The Braff Group is the leading merger and acquisition advisory firm specializing in the specialty pharmacy, infusion therapy, home health care, hospice, behavioral health and social services, home medical equipment, and health care staffing market sectors.  The firm provides an array of transactional advisory services including sell side representation, debt and equity recapitalizations, strategic planning, and valuation.  Since being founded in 1998, The Braff Group has completed more than 160 transactions. In 2009, based upon deals completed, the firm was ranked number 1 in US Healthcare Services transactions (Source: Thomson Reuters).

Contact

Enhanced Equity Fund    Roland Tomforde; Broadgate Consultants  212-232-2222

The Braff Group Karen Vechter 412-833-5733